Millennium Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $929K | Buy |
+663,269
| New | +$929K | ﹤0.01% | 3066 |
|
|
2025
Q1 | – | Sell |
-117,454
| Closed | -$148K | – | 3954 |
|
|
2024
Q4 | $148K | Sell |
117,454
-42,669
| -27% | -$53.8K | ﹤0.01% | 3733 |
|
|
2024
Q3 | $301K | Buy |
160,123
+139,085
| +661% | +$261K | ﹤0.01% | 3546 |
|
|
2024
Q2 | $156K | Sell |
21,038
-46,373
| -69% | -$343K | ﹤0.01% | 3638 |
|
|
2024
Q1 | $528K | Buy |
+67,411
| New | +$528K | ﹤0.01% | 3273 |
|
|
2023
Q2 | – | Sell |
-231,172
| Closed | -$2.19M | – | 4210 |
|
|
2023
Q1 | $2.19M | Buy |
231,172
+177,392
| +330% | +$1.68M | ﹤0.01% | 2490 |
|
|
2022
Q4 | $573K | Buy |
53,780
+4,632
| +9% | +$49.4K | ﹤0.01% | 3544 |
|
|
2022
Q3 | $363K | Buy |
49,148
+16,008
| +48% | +$118K | ﹤0.01% | 4071 |
|
|
2022
Q2 | $159K | Buy |
+33,140
| New | +$159K | ﹤0.01% | 4549 |
|
|
2021
Q1 | – | Sell |
-55,020
| Closed | -$429K | – | 4457 |
|
|
2020
Q4 | $429K | Buy |
+55,020
| New | +$429K | ﹤0.01% | 3332 |
|
|
2019
Q3 | – | Sell |
-509
| Closed | -$4K | – | 3479 |
|
|
2019
Q2 | $4K | Buy |
+509
| New | +$4K | ﹤0.01% | 3435 |
|
|
2018
Q4 | – | Sell |
-540
| Closed | -$12K | – | 3334 |
|
|
2018
Q3 | $12K | Sell |
540
-579
| -52% | -$12.9K | ﹤0.01% | 3447 |
|
|
2018
Q2 | $21K | Sell |
1,119
-4,349
| -80% | -$81.6K | ﹤0.01% | 3358 |
|
|
2018
Q1 | $60K | Buy |
+5,468
| New | +$60K | ﹤0.01% | 3288 |
|
|
2015
Q4 | – | Sell |
-5,501
| Closed | -$292K | – | 3184 |
|
|
2015
Q3 | $292K | Buy |
5,501
+75
| +1% | +$3.98K | ﹤0.01% | 2723 |
|
|
2015
Q2 | $431K | Buy |
+5,426
| New | +$431K | ﹤0.01% | 2506 |
|